For children who cannot swallow tablets or need individualized doses, the pharmacy often becomes the final step in manufacturing their medicine. Ready-to-use liquid formulations can remove that preparation burden, but hospital formulary access is an important step toward getting them into routine care.Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are climbing Friday after the company announced that Arbli™, its losartan potassium oral suspension, has been added to the formularies of three leading U.S. pediatric academic medical centers and hospitals. The institutions specialize in ...